Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

The first time around, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...

Now, drinkers are motioning for a cocktail reformation — specifically, smaller aperitifs suitable for shrinking stomachs and the health-conscious in the post-Ozempic world. “There was a ...

Starting in 2022, increased demand led to shortages of semaglutide injections sold by Novo Nordisk under the brand names Ozempic and ... Although health care providers say they have noticed ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...